Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (431-440 of 606) with videos related to

Pageof 61
Sort By:
Bioorganic & Medicinal Chemistry|August 2, 2002
Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphanAkihiro Hashimoto, Arthur E Jacobson, Richard B Rothman, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinansJohannes Schütz, Christina M Dersch, Robert Horel, et al.
Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in miceB Lu, C Ebensperger, Z Dembic, et al.
Neuropharmacology|May 1, 1991
(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulationH Xu, C H Kim, Y C Zhu, et al.
NIDA Research Monograph|January 1, 1991
[3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligandsR B Rothman, A Mahboubi, A A Reid, et al.
Molecular Pharmacology|February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligandsR B Rothman, A Reid, A Mahboubi, et al.
Neuropeptides|October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitroR B Rothman, V Bykov, A Reid, et al.
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
Pageof 61

Showing results (431-440 of 606) with videos related to

Sort By:
Pageof 61
Bioorganic & Medicinal Chemistry|August 2, 2002
Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphanAkihiro Hashimoto, Arthur E Jacobson, Richard B Rothman, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinansJohannes Schütz, Christina M Dersch, Robert Horel, et al.
Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in miceB Lu, C Ebensperger, Z Dembic, et al.
Neuropharmacology|May 1, 1991
(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulationH Xu, C H Kim, Y C Zhu, et al.
NIDA Research Monograph|January 1, 1991
[3H]1,3-Di(2-tolyl)guanidine labels two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel blockers and sigma ligandsR B Rothman, A Mahboubi, A A Reid, et al.
Molecular Pharmacology|February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligandsR B Rothman, A Reid, A Mahboubi, et al.
Neuropeptides|October 1, 1988
A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitroR B Rothman, V Bykov, A Reid, et al.
European Journal of Medicinal Chemistry|November 22, 2012
Probes for narcotic receptor mediated phenomena. 46. N-substituted-2,3,4,9,10,10a-hexahydro-1H-1,4a-(epiminoethano)phenanthren-6- and 8-ols - carbocyclic relatives of f-oxide-bridged phenylmorphansFuying Li, Jason A Deck, Christina M Dersch, et al.
European Journal of Pharmacology|January 24, 1989
Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sitesR B Rothman, V Bykov, J B Long, et al.
Pageof 61